Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Back Musculoskelet Rehabil ; 28(4): 783-7, 2015.
Article in English | MEDLINE | ID: mdl-25736952

ABSTRACT

BACKGROUND: Low back pain (LBP) is a public health problem commonly seen in all societies. OBJECTIVE: The aim of this study was to determine the prevalence and specific risk factors of low back pain (LBP) in the central and outlying districts of the province of Trabzon, a Black Sea region of Turkey. METHOD: A random sample of 7897 (4006 men and 3789 women) adults was collected by using sampling techniques of stratification. In this study questionnaires were completed at face-to-face interviews with participants selected on the basis of place of residence, gender and age group. The used variables in this study were: use of cigarettes, status of marriage, level of education, and presence of chronic disease, the prevalence of lifetime LBP and of LBP in the preceding year. Chronic LBP was determined as being present for more than 6 weeks. RESULTS: The lifetime prevalence of LBP in the general population was determined at 62.1%. Prevalence in the preceding year was 46.1%, and that of LBP lasting more than six week was 18.1%. Lifetime prevalence of LBP, prevalence of LBP in the preceding year and prevalence of pain lasting more than six week were all statistically significantly higher in women (p< 0.001). Use of cigarettes, female gender, marriage, a low level of education and presence of chronic disease were identified as independent risk factors for LBP (p< 0.001). CONCLUSION: Lower back pain is a common public health problem. Recommendations were made for local health services to prevent LBP, including health education through combating chronic diseases, reducing cigarette consumption, improvement of working environments and life styles.


Subject(s)
Chronic Pain/epidemiology , Low Back Pain/epidemiology , Risk Assessment , Surveys and Questionnaires , Adult , Aged , Black Sea , Female , Humans , Life Style , Male , Middle Aged , Prevalence , Risk Factors , Turkey/epidemiology , Young Adult
2.
Scand J Rheumatol ; 34(2): 140-4, 2005.
Article in English | MEDLINE | ID: mdl-16095011

ABSTRACT

OBJECTIVE: The objectives of this study were to determine the prevalence of fibromyalgia syndrome (FMS) in women aged 20-64 in the city of Trabzon, Turkey, and to evaluate associated demographic variables. METHODS: A minimum of 1825 subjects eligible for the study was calculated, and 2000 subjects were eventually planned for inclusion. Of these, 1930 subjects participated in the screening phase (a participation rate of 96.5%). The screening protocol included several interview items that have been defined as components of FMS. Subjects were also asked questions concerning demographics. Individuals with positive screening results were invited to be examined by a specialist in physical medicine and rehabilitation in order to confirm or exclude FMS using the 1990 American College of Rheumatology (ACR) classification criteria. RESULTS: Seventy of the 1930 women were diagnosed with FMS. The prevalence of fibromyalgia was 3.6% (95% CI 2.8-4.4). The prevalence was highest in the 50-59 age group (10.1%, 95% CI 8.8-11.4), in the uneducated (10.7%, 95% CI 9.3-12.1), in the widowed (8.8%, 95% CI 7.5-10.1), and in subjects with an annual household income of < USD 2000 (7.3%, 95% CI 6.1-8.5). CONCLUSION: This cross-sectional study is the first report of the prevalence of FMS in Turkey. These data will assist decision-making in the health system.


Subject(s)
Fibromyalgia/epidemiology , Adult , Demography , Female , Fibromyalgia/physiopathology , Humans , Interviews as Topic , Middle Aged , Pain , Prevalence , Turkey/epidemiology
3.
Int J Neurosci ; 110(1-2): 9-23, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11697214

ABSTRACT

The aims of this study were (i) to examine whether patients with major depressive disorder (MDD) differ from healthy control subjects with respect to isokinetic muscle performance (IMP) as measured by a dynamometer; (ii) to investigate the effect of subchronic treatment on the IMP in depressed patients. Thirty-eight patients with MDD, and 41 sex- and age-matched healthy controls participated in this study. The severity of depression and anxiety levels were evaluated by the Hamilton Depression and Anxiety Scales. Quadriceps and hamstring IMPs were determined by using an isokinetic dynamometer before and after subchronic antidepressant treatment. The patients had lower IMP levels than healthy controls. After treatment for three months with selective serotonin reuptake inhibitors, the IMP levels increased significantly. These findings suggest that (i) MDD may be characterized by reduced IMP levels; and (ii) treatment with antidepressants may increase the IMP levels, as a state marker for depression. It was concluded that (i) isokinetic muscle performance may be used as a state marker for monitoring antidepressant drug effects on MDD; (ii) isokinetic exercise increasing IMP may be used in the treatment of depression.


Subject(s)
Antidepressive Agents/pharmacology , Depressive Disorder, Major/drug therapy , Isometric Contraction/drug effects , Muscle, Skeletal/drug effects , Adult , Aged , Antidepressive Agents/therapeutic use , Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/psychology , Female , Humans , Male , Middle Aged , Severity of Illness Index
4.
Int J Neurosci ; 109(3-4): 149-64, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11699327

ABSTRACT

The aims of this study were (i) to examine whether patients with major depressive disorder (MDD) differ from healthy control subjects with respect to isokinetic muscle performance (IMP) as measured by a dynamometer; (ii) to investigate the effect of subchronic treatment on the IMP in depressed patients. Thirty-eight patients with MDD, and 41 sex- and age-matched healthy controls participated in this study. The severity of depression and anxiety levels was evaluated by the Hamilton Depression and Anxiety Scales. Quadriceps and hamstring IMPs were determined by using an isokinetic dynamometer before and after subchronic antidepressant treatment. The patients had lower IMP levels than healthy controls. After treatment for three months with selective serotonin reuptake inhibitors, the IMP levels increased significantly. These findings suggest that (i) MDD may be characterized by reduced IMP levels; and (ii) treatment with antidepressants may increase the IMP levels, being a state marker for depression. It was concluded that (i) isokinetic muscle performance may be used as a state marker for monitoring antidepressant drug effects on MDD; (ii) isokinetic exercise increasing IMP may be used in the treatment of depression.


Subject(s)
Antidepressive Agents/pharmacology , Depressive Disorder, Major/drug therapy , Isometric Contraction/drug effects , Muscle, Skeletal/drug effects , Psychomotor Performance/drug effects , Adult , Aged , Antidepressive Agents/therapeutic use , Humans , Middle Aged , Psychiatric Status Rating Scales
5.
Heart ; 85(4): E7, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11250984

ABSTRACT

Behçet's disease is recognised as a chronic multisystem disorder with vasculitis as its underlying pathological process. Cardiac involvement is rare and often associated with poor prognosis. A case of a 33 year old man with Behçet's disease, presenting with a large right ventricle and right atrial thrombus, is reported. Two dimensional (cross sectional), colour Doppler, and transoesophageal echocardiography, angiography, computed tomography, and magnetic resonance imaging were used to diagnose the disease. With cyclophosphamide and dexamethasone treatment, the cardiac lesions progressively resolved.


Subject(s)
Behcet Syndrome/complications , Heart Diseases/complications , Thrombosis/complications , Adult , Anti-Inflammatory Agents/therapeutic use , Anticoagulants/therapeutic use , Behcet Syndrome/diagnosis , Behcet Syndrome/drug therapy , Colchicine/therapeutic use , Cyclophosphamide/therapeutic use , Dexamethasone/therapeutic use , Drug Therapy, Combination , Echocardiography, Doppler, Color , Echocardiography, Transesophageal , Heart Atria/diagnostic imaging , Heart Diseases/diagnosis , Heart Diseases/drug therapy , Heart Ventricles/diagnostic imaging , Humans , Immunosuppressive Agents/therapeutic use , Male , Thrombosis/diagnosis , Thrombosis/drug therapy , Warfarin/therapeutic use
6.
Clin Genet ; 45(4): 217-8, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8062443
SELECTION OF CITATIONS
SEARCH DETAIL
...